Stetz Gary S. (CIK 1532793) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-12). Recent activity: Buy HEPA (2.0M shares), Sell CNTN (10,000 shares), Sell CNTN (10,000 shares), Sell CNTN (15,000 shares), Sell CNTN (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Hepion Pharmaceuticals, Inc. (HEPA) | Interim CEO | Buy | 2.0M | $100,000 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 10,000 | $34,500 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 10,000 | $34,500 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 15,000 | $51,000 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 15,000 | $51,150 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 15,000 | $51,150 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 10,000 | $34,000 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 12,851 | $44,207 |
| 2026-05-27 | Canton Strategic Holdings, Inc. (CNTN) | Director | Sell | 12,500 | $43,375 |
| 2026-04-27 | Hepion Pharmaceuticals, Inc. (HEPA) | Interim CEO | Buy | 1.2M | $50,000 |
Source: SEC Form 4 filings · as of 2026-08-12